United States · FDA National Drug Code directory

levocetirizine dihydrochloride

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
37808-126_a08f35dd-f3d5-5689-c975-0ed213c90c7d
Product NDC
37808-126
Form
TABLET, COATED
Composition / generic term
levocetirizine dihydrochloride
Labeler
HEB
Marketing category
ANDA
Marketing start / end (source format)
20190615
Source listing expiry
20271231

Source-listed ingredients

  • LEVOCETIRIZINE DIHYDROCHLORIDE — 5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 2 BLISTER PACK in 1 BLISTER PACK (37808-126-10) / 5 TABLET, COATED in 1 BLISTER PACK · 37808-126-10
  • 1 BOTTLE in 1 BOTTLE (37808-126-35) / 35 TABLET, COATED in 1 BOTTLE · 37808-126-35
  • 1 BOTTLE in 1 CARTON (37808-126-80) / 80 TABLET, COATED in 1 BOTTLE · 37808-126-80

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →